OpGen, Inc. (LON: 0A8L)
London
· Delayed Price · Currency is GBP · Price in USD
1.560
0.00 (0.00%)
At close: Jan 21, 2025
OpGen Company Description
OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally.
The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits.
It provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services.
OpGen, Inc. was incorporated in 2001 and is headquartered in Rockville, Maryland.
OpGen, Inc.
Country | United States |
Founded | 2001 |
Industry | In Vitro and In Vivo Diagnostic Substances |
Employees | 93 |
CEO | Honjian Tan |
Contact Details
Address: 9717 Key West Avenue Rockville, Delaware 20850 United States | |
Phone | 240 813 1260 |
Website | opgen.com |
Stock Details
Ticker Symbol | 0A8L |
Exchange | London Stock Exchange |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
SIC Code | 2835 |
Key Executives
Name | Position |
---|---|
Honjian Tan | Chief Executive Officer |
David Caplon | Chief Financial Officer |
Mohd Azudin | Chief Operating Officer |